QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=9FDD38A6EA63A9F47B6E0C67EAF501CB;jsessionid=37E7461F05073B2CC9F24D0707B62E1C;jsessionid=CDC4FC58CCD8930216A8DE706F928CC8;jsessionid=4D8AE65513C79E376FF81F69930D8CDC (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
3. Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longi…
4. ATXN2 is a target of N-terminal proteolysis.
5. Abnormal open states patterns in the ATXN2 DNA sequence depends on the CAG repeats length.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=9FDD38A6EA63A9F47B6E0C67EAF501CB;jsessionid=37E7461F05073B2CC9F24D0707B62E1C;jsessionid=CDC4FC58CCD8930216A8DE706F928CC8;jsessionid=4D8AE65513C79E376FF81F69930D8CDC